Raymond F. Schinazi
125Patents
31h-index
86Co-inventors
93Inventor score
Filing activity: May 1, 1986 → Sep 5, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6348587B1 | 2′-Fluoronucleosides | Chemistry; Metallurgy | 179 | Expired |
| US6911424B2 | 2′-fluoronucleosides | Chemistry; Metallurgy | 123 | Expired |
| US5210085A | Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds | Chemistry; Metallurgy | 108 | Expired |
| US7307065B2 | 2′-Fluoronucleosides | Chemistry; Metallurgy | 105 | Expired |
| US5814639A | Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds | Chemistry; Metallurgy | 90 | Expired |
| US4916122A | 3'-Azido-2',3'-dideoxyuridine anti-retroviral composition | Chemistry; Metallurgy | 82 | Expired |
| US5703058A | Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent | Chemistry; Metallurgy | 81 | Expired |
| US5914331A | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane | Chemistry; Metallurgy | 79 | Expired |
| US8609627B2 | Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections | Emerging Cross-Sectional Technologies | 71 | Active |
| US5118672A | 5'-diphosphohexose nucleoside pharmaceutical compositions | Chemistry; Metallurgy | 69 | Expired |
| US5905070A | 5--Caboxamido or 5--fluoro!--2', 3'--unsaturated or 3'--modified!--pyrimidine nucleosides | Chemistry; Metallurgy | 67 | Expired |
| US5179104A | Process for the preparation of enantiomerically pure .beta.-D-(-)-dioxolane-nucleosides | Chemistry; Metallurgy | 62 | Expired |
| US8168583B2 | 2-fluoronucleosides | Chemistry; Metallurgy | 61 | Active |
| US6232300A | Treatment of HIV by administration of .beta.-D-2', 3'-didehydro-2',3'-dideoxy-5-fluorocytidine (D4FC) | Chemistry; Metallurgy | 61 | Expired |
| US5571666A | Thiazine dyes used to inactivate HIV in biological fluids | Human Necessities | 54 | Expired |
| US5444063A | Enantiomerically pure .beta.-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity | Chemistry; Metallurgy | 53 | Expired |
| US5599796A | Treatment of urogenital cancer with boron neutron capture therapy | Chemistry; Metallurgy | 53 | Expired |
| US5405598A | Sensitizing agents for use in boron neutron capture therapy | Chemistry; Metallurgy | 51 | Expired |
| US7772208B2 | 2′,3′-dideoxynucleoside analogues for the treatment or prevention of Flaviviridae infections | Chemistry; Metallurgy | 49 | Active |
| US6703396B1 | Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers | Chemistry; Metallurgy | 49 | Expired |
| US5462724A | Sensitizing agents for use in boron neutron capture therapy | Chemistry; Metallurgy | 49 | Expired |
| US5750493A | Method to improve the biological and antiviral activity of protease inhibitors | Emerging Cross-Sectional Technologies | 48 | Expired |
| US6391859B1 | [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides | Chemistry; Metallurgy | 48 | Expired |
| US6949522B2 | β-2′- or 3′-halonucleosides | Chemistry; Metallurgy | 44 | Expired |
| US6680303B2 | 3′,5-difluoro-2′,3′-didehydropyrimidine nucleosides and methods of treatment therewith | Chemistry; Metallurgy | 44 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.